View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
One £20,000 grant will be awarded each year for five years, starting in 2019 (making a £100,000 total by 2023) to fund research that focuses on mental health and wellbeing within the veterinary professions, including areas such as prevention, diagnosis, intervention and treatment.
Applications are welcome from individuals at all stages of their research careers, including those who have not previously been published, with research proposals relating to any aspect of mental health or wellbeing in the veterinary professions. Researchers must be affiliated with a university, and ethical approval must be in place.
RCVS CEO, Lizzie Lockett, said: "Sarah Brown was a talented veterinary surgeon who was passionate about her profession. She was respected and loved by so many people and worked hard to support others. So it is fitting that, with the blessing of Sarah’s family, we are able to launch this grant in her memory. It’s only by improving the veterinary mental health evidence base that we will be able to hone the interventions and support that is available to members of the veterinary team."
Applicants should send their research proposal, along with a CV and short biography for all lead researchers, to Lisa Quigley, Mind Matters Initiative Manager, by 5pm on Friday 31 May 2019.
Each proposal should be a maximum of 3,000 words and should include aims, methods, ethical considerations, proposed timelines, and a bibliography. Any academic literature referred to within the proposal should be accurately referenced. The winner of the grant will be decided in June 2019, with the winner then receiving their award at Royal College Day in London on Friday 12 July 2019.
The recipient of the Sarah Brown Mental Health Research Grant for 2019 will be invited to present their research findings at the biennial Mind Matters Initiative Research Symposium in 2021.
Applications are particularly welcomed from those at an early stage in their research career. Guidance on how to prepare a research proposal is available at: https://esrc.ukri.org/funding/guidance-for-applicants/how-to-write-a-good-research-grant-proposal
Elanco Animal Health is reminding vets about the importance of correctly interpreting oocyst counts in the diagnosis of coccidiosis during the post lambing period.
The company says scouring lambs that are failing to thrive should immediately ring the alarm bells for coccidiosis. Typically, oocyst counts of >20,000 per gram are cited as diagnostic for coccidiosis in sheep, but counts of up to 100,000 oocysts per gram have been reported in apparently healthy lambs and disease can also occur in the presence of low or negligible counts where there is gut damage but before oocysts have been shed.1 These discrepancies can lead to misdiagnosis and as such, oocyst counts should always be interpreted with care.
Oocysts of the fourteen Eimeria species described as specific to sheep are indistinguishable from each other by eye and only two species - E. ovinoidalis and E. crandallis, are actually pathogenic.1 For this reason, diagnosing coccidiosis based on clinical signs of diarrhoea and oocysts in their faeces alone can generate false positives. This could lead to important differentials, such as Nematodirus battus infection (for lambs at pasture) being left untreated.
According to the company, false negatives are also a concern, particularly as prompt treatment of clinical cases with an anti-coccidial, such as diclazuril (Vexocan® 2.5mg/ml oral suspension) has been proven to reduce the convalescence period.2 Shedding of oocysts varies with disease progression and faecal counts can fluctuate significantly.3 For example, a delay between the development of clinical signs and oocysts appearing in faeces is common. Another possibility is sub-clinical disease, with affected lambs showing no typical outward signs. The gut damage caused by the parasite can be significant in these animals though, adversely affecting growth rates.
Elanco says that for reliable diagnosis of coccidiosis, faecal oocyst counts should be considered alongside disease and farm history, followed with Eimeria species identification if possible. The disease typically affects groups of lambs aged between 3-8 weeks old and is often triggered by a stressor such as castration, weaning, turnout and/or bad weather. If clinical signs appear around three weeks after such an event, the suspicion of coccidiosis can be heightened. For some farms, predictable stressors cause disease outbreaks year after year and in these cases, a metaphylactic dose of Vecoxan® can be administered to susceptible lambs 14 days after the trigger event.
Finally, the company says veterinary surgeons should also not forget the importance of good management when advising farmers about coccidiosis control. Lambing pen and high traffic area hygiene and age batching lambs are essential for long term control.
References
The survey of 1,019 dog owners was conducted by petbuzz in December 2022.
Veterinary cardiology specialist, Dr Rachel James, said: “The CKCS has long been a very popular breed of dog in high demand, due to their loving and placid nature making them perfect family pet.
"We know that sadly at least 50% of CKCS have evidence of MVD disease by the time they are five, with 98% of dogs affected in their lifetimes.
"However, we can help our clients when selecting this breed to choose a puppy that is less likely to develop MVD at an early age, by utilising the heart testing scheme (Doppler heart testing).
"Prospective owners should be asking to see test results for the parents, grandparents, and even better great grandparents too, on both maternal and paternal sides.
"In addition breeders need more support and education to encourage the use of the heart testing scheme and how this can enable them to choose the best dogs to breed from.
"Furthermore we should be encouraging breeders to breed from dogs only when they are at least 3 years of age.”
Vita Animal Health commissioned the survey to raise awareness of the condition and to remind owners to use their vet’s expertise.
Vita’s veterinary nurse, Tara Evans, said: “The CKCS is a very popular breed of dog, perhaps set to be more so now King Charles III is reigning monarch.
"This survey has shown that awareness of mitral valve disease – which is very common in this breed – is not as good as it could be.
"We want to support vets in raising awareness and have useful resources such as our heart disease infographic (www.vitaanimalhealth.com/common-signs-of-heart-disease) that we welcome all vets in using.”
The clinic offers Specialist care primarily for patients with osteoarthritis pain, but also those with chronic pain caused by other conditions, such as cancer, dental and ear diseases, spinal disease and feline hyperaesthesia syndrome.
BVS says cats and dogs coming to the clinic will get the highest level of care with a specialist assessment from Jo, who also also works closely with the orthopaedic and neurology services to offer a global and holistic approach.
The assessment will identify signs of chronic pain, gauge the severity, and also evaluate the impact of the condition on the animal’s quality of life.
Jo says it is important to identify these conditions as early as possible, as instigating pain management early helps to dampen down pain signals and reduce overall upregulation of the pain pathways.
To that end, Jo uses validated clinical metrology instruments (owner questionnaires) to measure the severity of pain, especially during initial appointments.
Should a condition be detected, Jo and her team will be able to offer pharmacotherapy, intra-articular and epidural injections and acupuncture.
Jo also works closely with physiotherapists and hydrotherapy services, which can be used as adjunctive therapy.
Jo said, said: “Many cats and dogs will experience chronic pain. These cases need to be thoroughly investigated to ensure that the cause of pain is properly identified and treatment quickly provided. We are very pleased to be able to open our new chronic pain clinic for cat and dog owners in the South West today to provide this essential service.”
https://www.bristolvetspecialists.co.uk
The researchers say that previous research suggests that approximately 10% of diabetic cats are euthanised at the time of diagnosis, making it a significant cat welfare issue.
However, this figure was largely based on questionnaire-based research from several global locations.
This new study followed the survival of 1,053 cats with confirmed diabetes mellitus under UK primary-care practices in 2019, providing the most up-to-date baseline data on early death among diabetic cats in the UK, as well as examining risk factors for the development of diabetes among UK pet cats.
The study found:
Based on these findings, the researchers encourage veterinarians to more actively discuss diabetes mellitus risk with cat owners, particularly those with Burmilla and Burmese breeds, in the hope that raising awareness of the disease might improve outcomes through earlier diagnosis, and by taking actions that might prevent diabetes mellitus development in the first instance, such as preventing cats becoming obese.
Dr Oliver Waite, Senior Lecturer in Small Animal Medicine at Murdoch University, and primary author of the paper, said: “We hope that this new, large scale epidemiological study, investigating the second most common endocrine disease in cats, will help to highlight current as well as future areas to improve cat welfare.
"This is an exciting time for the management of diabetic cats but more work is still needed!”
Dr Dan O’Neill, Associate Professor in Companion Animal Epidemiology at the RVC, and co-author of the paper, said: “This new VetCompass study shows the value of everyone working in primary care practice sharing their anonymised clinical data to get a better understanding of real-world animal health.
"Awareness of the scale of the diabetes mellitus issue revealed here can empower veterinary professionals to engage in more conversations with owners about diabetes mellitus prevention in predisposed cats.”
Reference
The Committee heard a number of charges against Dr Davies.
Two of the charges related to convictions for drink driving in March 2014 and October 2015, for which she received driving bans for 17 months and 45 months respectively.
The third charge related to her breaching a number of undertakings she had entered into as part of the College’s Health Protocol, including her consuming alcohol on four occasions between May 2015 and January 2016 and missing a pre-arranged appointment.
The fourth charge related to being under the influence of alcohol on three occasions while she was on duty as a veterinary surgeon in December 2016 which was also in breach of her undertakings under the Health Protocol.
At the outset of the hearing Dr Davies admitted all five charges against her and that this meant she was unfit to practise veterinary surgery and that she was guilty of disgraceful conduct in a professional respect. The Committee accepted her admissions and found, with the exception of one allegation, that her conduct was disgraceful in a professional respect.
In considering the sanction for Dr Davies, the Committee considered a number of aggravating factors including the risk of injury to animals in her care; the fact that the misconduct was sustained or repeated over a period of time; the fact that her conduct contravened the advice issued to her by the Preliminary Investigation Committee upon entering the Health Protocol; and the fact that Dr Davies was in a position of trust and responsibility during the occasions she was under the influence of alcohol in December 2016 as she was the sole veterinary surgeon on duty.
In its consideration of sanction the Committee heard a submission from counsel for Dr Davies for the decision on sanction to be postponed for six months on the basis of Dr Davies complying with nine separate undertakings, including one not to practise as a vet. In making this application Dr Davies’ counsel told the Committee that her client was remorseful over her conduct and that she had been abstinent from alcohol since August 2017 after referring herself for treatment.
The Committee decided to postpone the hearing for six months on the basis of Dr Davies’ fulfilling her undertakings. These include not to practise veterinary surgery and to remain abstinent from alcohol during the period of postponement.
Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee accepted Dr Davies’ evidence and found her to have genuine remorse. Further it recognised that Dr Davies was fully committed to understanding and addressing her alcohol problem. Her efforts to avoid any repetition of misconduct were evident from the detailed undertakings which she had volunteered.
"The Committee took into account that Dr Davies had a hitherto unblemished career prior to her alcohol problem, having qualified in 1996. Further it noted that she had not worked as a veterinary surgeon since December 2016.
"The Committee therefore decided to postpone judgement so that Dr Davies could continue to demonstrate her improved insight and her abstinence from alcohol.”
The divestment is expected to be concluded in mid-2020, and Bayer intends to exit its stake in Elanco over time.
Bayer says that combining Elanco and Bayer Animal Health will create the number two animal heath company, with top three positions across a broad range of species and geographies. It also enhances Elanco’s portfolio of leading global brands and bolsters its innovation capabilities and R&D pipeline.
Jeffrey N. Simmons, president and chief executive officer of Elanco, said: "Combining Elanco’s strong relationship with veterinarians and Bayer’s leadership in retail and e-commerce will ultimately benefit all our customers. We look forward to joining our complementary portfolios and capabilities to build a fully focused animal health company, providing a sustained flow of innovation for farmers, veterinarians and pet owners."
The self-adhesive dressing, which uses a patented natural polymer, adapts to any part of the body and sets fast, acting as a waterproof barrier to the external environment which shields the site from unwanted moisture and bacterial ingress and allows the tissue underneath to repair in a protected environment.
It is proven to prevent the loss of therapeutic sprays when it is used as a barrier1.
The company says NoBACZ Bovine is easy to apply with a clean gloved hand and offers up to seven days’ protection without the need to reapply.
It is suitable for use on any site of the body, except the eyes, and has been especially widely used on hooves, horn buds and udders.
The liquid barrier dressing does not need to be removed as it will self-degrade and its ingredients dissolve naturally with no residue.
Dr Jonathan Powell, Director of Biomineral Research and Imaging at the University of Cambridge’s Department of Veterinary Medicine, and chief executive officer and co-founder of NoBACZ Healthcare, said: “Following several years of research at the University of Cambridge and comprehensive market analysis which identified an unmet need across the farming industry, we are absolutely delighted to launch NoBACZ Bovine, which offers unparalleled protection against harsh farm conditions, revolutionising wound protection in cattle and enhancing the health and welfare of the national herd.”
Mike Kerby, veterinary surgeon from Synergy Farm Health, who has used NoBACZ Bovine over many months, added: “I have been using NoBACZ Bovine for a while in cattle affected with UCD (udder cleft dermatitis) and DD (digital dermatitis) lesions as well as on wounds and granulomas.
"It is my clinical impression that it counters bacterial colonisation rapidly and promotes re-epithelialisation, which in turn helps to prevent the occurrence of proud flesh or reduces the mass of any existing granulomata.
"Application is simple and quick, with clients also finding it easy to reapply regularly within set treatment protocols.
"In addition to this, it was seen as a huge advantage that bandages and their removal are not involved, nor are antibiotics, making it labour saving, sustainable and eco-friendly.”
www.nobacz.com
The Fédération Équestre Internationale (FEI) has added Metacam for Horses to its 'list of detection times'.
According to the manufacturer, Boehringher Ingelheim Vetmedica, Metacam (meloxicam) is the first preferential COX-2 inhibitor to be added to this list, and has stated plasma and urine detection times of 72 hours administered intravenously or orally1. This is the shortest urine detection time of the NSAIDs available for use in horses, and compares to the 168-hour (7 days) detection time for phenylbutazone stated by the FEI.
Craig Beck, equine sales and marketing manager for Boehringer Ingelheim in the UK and Ireland said: "We have been very happy to work in partnership with the FEI to provide the robust data that has supported the FEI in their analysis of Metacam. Metacam is an important addition to the FEI list, that will help vets treating competition horses. There is now a modern and proven NSAID which extends the therapeutic options available to vets."
Metacam is licensed in horses for the alleviation of inflammation and relief of pain associated with musculo-skeletal disorders or colic.
For further information, please contact your Boehringer Ingelheim Vetmedica territory manager or call 01344 746959.
1 Detection Time agreed with the European Horse Racing Scientific Liaison Committee (EHSLC)
Latest figures from the Food Standards Agency (FSA) indicate that 22% of sheep and goats (3 million) are not stunned before slaughter1.
This is an increase from 2013 when it was estimated 15% (2 million) of sheep and goats were slaughtered without stunning.
At the same time, in a response to a parliamentary question2 from Kerry McCarthy MP (Bristol East), Defra has admitted that it does not hold data on how much of this non-stunned meat is exported.
The BVA says a recent trade deal with Saudi Arabia could greatly increase the exports of British lamb and other meat, some of which may be from non-stun slaughter. Information on the lamb market also indicates that exports in general (especially to non-EU countries) are on the increase, with total export volumes up 14% in 2017 and non-EU volumes growing to 5,400 tonnes – up two-thirds on the previous year3.
The BVA is calling for the timely provision of information on non-stun exports, firstly to ascertain the extent to which the UK is exporting meat from these sources and secondly to inform potential measures to ensure supply matches rather than exceeds domestic demand.
Other EU countries that allow non-stun slaughter have measures in place to limit the export of non-stun meat to help ensure that meat killed by this method is for the domestic market. For example, Germany requires that abattoirs apply for a licence by defining the number of animals to undergo non-stun slaughter to meet local demand only.
BVA President, John Fishwick, said: "Each year millions of animals in the UK are not stunned before slaughter and BVA will continue to push for an end to non-stun slaughter in the interests of animal welfare. The latest FSA figures suggest that a sizeable proportion of sheep and goats that are slaughtered in the UK are done so without stunning and that this seems to outstrip the requirements of the religious communities who consume meat that has been slaughtered in this way.
"It is difficult to unpick the possible factors that contribute to this mismatch but an essential step to understanding this better would be to provide data on how much, if any, non-stun meat is exported abroad. With Brexit on the horizon and in the light of announcements about export deals with non-EU countries, there is a pressing need for clarity on the quantities and destinations of exports of non-stun meat.
"While not illegal, if meat from non-stun religious slaughter is exported we consider this to be outside the spirit of the legislation which allows non-stun as a derogation from the law to meet the needs of religious communities."
The first is to confirm officially that Suprelorin, it's non-surgical alternative for neutering male dogs, may be implanted by RVNs under the direction of a veterinary surgeon under Schedule 3 of the Veterinary Surgeons Act.
The company is also hosting two free webinars for nurses to learn more about neutering: The Science of Canine Castration and Practical Tips for Clinics, presented by Dr Michelle Kutzler and Nicola Lakeman on Thursday 9th December 2021, and Behaviour in Post-Pandemic Puppies and Practical Tips for Clinics, presented by Stephanie Hedges and Nicola Lakeman on Thursday 16th December 2021.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: "A huge surge in dog ownership in the last two years, combined with the additional pressures of Covid-19, has massively increased pressures on veterinary teams.
"At the same time we know that pet owner attitudes to surgical neutering is changing with 1 in 3 pet owners saying that they would look at alternative methods to surgical castration1.
"Suprelorin offers practices the opportunity to utilise the skills of their RVNs to provide a choice to clients when it comes to neutering and help to ease pressures on surgical waiting lists".
At a hearing in April Dr Johnston had admitted all the charges against him, which related fraudulent claims for the treatment of animals, two of which were fictitious, where he arranged for the insurance claims to be diverted and paid into a personal bank account.
Dr Johnston had admitted all the charges against him as well as admitting that his conduct was dishonest and amounted to serious professional misconduct.
Committee Chair Paul Morris said: “The Committee has no hesitation in concluding that the respondent’s dishonest conduct will have severely undermined the confidence of the public in the veterinary profession and, further, that his conduct fell far short of the standards and conduct properly to be expected of a member of the veterinary profession.
"The Committee is satisfied that this conduct by the respondent brought the profession into disrepute.”
The proceedings were then adjourned to allow a psychiatric report and other mitigation to be prepared.
At its resumed hearing on earlier this month, the Committee considered what sanction to impose.
The Committee found that aggravating features of his misconduct were that it was premeditated, carefully planned and sophisticated in that it involved the creation of numerous and extensive false clinical records to support his fraudulent claims.
It also considered the fact that he implicated an innocent professional colleague who worked alongside him at the practice, that he abused the trust placed in him by clients, that the dishonest conduct was repeated and that it involved significant financial gain in excess of £13,200 to be further aggravating features of his conduct
In terms of mitigation, the Committee accepted that he had made early admissions regarding his conduct to his employer and the College and accepted responsibility.
The Committee also heard that he had made attempts at remediation involving repayments of some of the sums lost by the practice and insurers.
It also considered positive testimonials from family and professional colleagues and the fact that Dr Johnston had taken significant steps to deal with the gambling addiction that was at the root cause of his misconduct.
Having considered all the evidence, the Committee decided to postpone its decision on sanction for a period of 2 years on the condition that Dr Johnston agree to undertakings including refraining from any form of gambling, subjecting himself to a close regime of support and supervision, and repaying some of the sums he had defrauded.
Paul added: “In reaching this conclusion the Committee wishes to make it clear that it has taken an exceptional course in this case.
"Ordinarily conduct of the type covered by the charges which this respondent has accepted will merit the imposition of a sanction of removal from the Register or a period of suspension from the Register.
"In this instance the Committee has found it possible to take the course that it has because it is satisfied that the respondent was, at the time, suffering from a recognisable psychiatric compulsive addiction… and that the fraudulent attempts by the respondent to obtain funds with which to gamble would not have occurred but for this psychiatric condition.
“The Committee further considers that the undertakings offered by the respondent will serve to reduce the risk that he will relapse into gambling again, for his conduct will be closely monitored and he will accept continuing support and guidance from the organisations currently assisting him.
“The Committee is also satisfied of the requirements that neither animals nor the public will be put at risk by this proposed course of action; that the respondent has demonstrated insight into the seriousness of his misconduct and that there is currently no significant risk of repeat behaviour; that his practicing standards are not in need of improvement so long as he continues to fulfil his CPD obligations; that the undertakings offered are capable of being met, are appropriate and are measurable; that there is evidence that his underlying medical problem is being appropriately addressed, will be monitored and reported on; and that he has responded positively to the opportunities for support and counselling which have been offered to him.”
If Dr Johnston fails to comply with his undertakings the Committee will reconvene and consider the charges with the full range of sanctions at its disposal.
www.rcvs.org.uk/disciplinary
The awards, which have in the past recognised the welfare achievements of veterinary surgeons, nurses and animal welfare professionals, will this year also recognise farming professionals. There is also a new award for an 'Outstanding Contribution to Animal Welfare'.
The award categories include:
Chris Laurence Vet of the YearDedicated to the head judge, Christopher Laurence, in recognition of a veterinary surgeon (either companion or farm animal) who demonstrates their commitment to the continuous improvement of animal health and welfare.
Vet Nurse of the YearAn award for a veterinary nurse (either companion or farm animal) who excels in their role by demonstrating and/or educating to the highest level of animal health and welfare.
Charity Team of the YearFor an inspiring team whose drive and passionate dedication has changed the lives of animals for the better.
Charitable Contribution of the Year – sponsored by Blue CrossFor an individual, in either a voluntary or paid role, who is constantly committed to making a difference to animal welfare.
International Cat Care Welfare of the Year – sponsored by International Cat CareFor an individual who has made a significant contribution to the development of feline welfare. The winner of this award is selected by International Cat Care and therefore this category is not open to nominations.
Farmer of the YearFor a farmer who strives to provide and encourage a high standard of animal welfare on their farm(s).
Farm Educator of the Year – sponsored by NADISTo acknowledge the work of a SQP, advisor, university or other educational institute, that works hard to research and educate on the importance and benefits of farm animal welfare.
Outstanding Contribution to Animal Welfare – sponsored by Your Dog and Your Cat magazinesThis award is for an individual or team who stands out from the crowd by influencing and significantly contributing to making a visible difference in the world of animal welfare. This award is selected by our judging panel, from all nominations received for 2019 and therefore, this category is not open for direct nominations.
If there is a veterinary surgeon, veterinary nurse, farmer, animal welfare professional or animal welfare team that you feel deserves to be recognised for their ongoing commitment to animal welfare, visit www.cevawelfareawards.com to nominate. Entries must be in by Friday 11th January 2019.
The winners and runners up will be honoured at a glittering ceremony taking place on the eve of BSAVA Congress on 3rd April 2019.
The deal is expected to complete by the middle of 2020.
According to the terms of the deal, Vetoquinol will acquire the Profender and Drontal product families, the intellectual property, registrations and other rights currently owned by Bayer AG’s animal health business.
Jeff Simmons, president and CEO of Elanco said: "We’re pleased with the continued progress on a number of fronts to move the acquisition of Bayer AG’s animal health business toward completion.
Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire the Profender and Drontal product lines that are highly valued by veterinarians and pet owners. The acquisition of these two strong brands is at the heart of our strategy. On the one hand, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. On the other hand, they will strengthen our portfolio of Essentials, the engine of our growth."
Companion Care Vets has launched a Graduate Development Programme to develop veterinary graduates into future partners in the business.
According to the company, seven graduates have so far joined the scheme. Five are from the Royal (Dick) School of Veterinary Studies in Edinburgh, one is from The Royal Veterinary College in London and one studied at the Univesitat Autònoma de Barcelona. Each has gone through a rigorous recruitment process devised by the Companion Care Vets HR team, and will be placed in one of the groups established surgeries, where the company will give them an understanding of the entire business from clinical to personal, commercial to management.
Jane Balmain, Managing Director of Companion Care Vets said: "One of my ambitions for Companion Care Vets is to ensure we play a significant role in developing standards in the veterinary profession and I believe that supporting talented veterinary graduates is key to this.
"Our rapidly expanding business is passionate about providing the highest level of pet healthcare and client service and we are proud to be able to help veterinary professionals realise their ambitions and full potential."
Placements last three years, during which Companion Care says each of the graduates will be closely mentored and their clinical learning will follow the framework developed by the RCVS as part of their Professional Development phase. Business support will be given via secondment to Companion Care's support services departments and theory based learning. All graduates are placed in practice from day one, building on their clinical experience.
One of the graduates, Katie Denholm said: "This graduate programme is a brilliant opportunity for me to put what I have learnt at University into practice. What really excited me was the modern surgeries, opportunity to be really hands-on and the added business-advice that will help me to realise my dream of one day, and I hope in the not too distant future, becoming a partner in my own practice."
Katie has been placed at Companion Care Vet's Chelmsford surgery, where veterinary surgeon and Joint Venture Partner Simone Dent said: "This scheme is a fantastic opportunity for graduates to gain all important clinical experience alongside the commercial aspects of a veterinary career. Being a vet these days affords enormous opportunities to build a successful business that provides satisfaction, financial reward and work-life balance. Katie will be given every opportunity to blossom as an integral part of our team learning, and having fun, every step of the way."
To find out more about the Graduate Development Programme please visit www.ccvets.co.uk or email graduates@companioncare.co.uk
The RCVS has accredited four more universities to assess modules for its Certificate in Advanced Veterinary Practice (CertAVP). This means that there are now 78 modules for candidates to choose from, with many modules available through more than one university, giving veterinary surgeons a real choice as to how they work towards postgraduate qualifications.
The RCVS CertAVP Subcommittee has approved applications from the Universities of Edinburgh, Glasgow, Liverpool and the West of England (in partnership with Hartpury College).
A very broad range of modules is now available, covering most species and many disciplines. They include some firsts for the CertAVP - equine modules will be available through both Edinburgh and Liverpool universities, and Edinburgh will also be assessing modules in equine dentistry, laboratory animal science and cattle and sheep medicine, amongst others. Glasgow's range includes modules in veterinary public health, as well as emergency critical care, while the University of the West of England's offering includes the key skills modules, and ‘B' modules in small animal, equine and production animal practice.
These universities now join the Royal Veterinary College and the Universities of Cambridge and Middlesex in being accredited to assess modules. While all of the accredited universities provide courses to support candidates working towards modules, including distance-learning options and online support, they must also offer an assessment-only route for those who prefer self-study, or who want to attend courses elsewhere.
The modular CertAVP was launched during 2007 and gives candidates the benefit of a mix and match style of learning. This aims to meet the needs of those who are committed to planned continuing professional development (CPD) but who need to balance this with busy practice life.
The new Certificate also better meets the needs of those whose practice interests change over the enrolment period, or who want to combine study across different species and disciplines to suit their practice caseload. Previously there was little flexibility built into the examination system.
"We are delighted that the list of modules available has nearly tripled this month," says Freda Andrews, RCVS Head of Education. "Interest in the new certificate is growing, and there are already around 200 people enrolled with RCVS for various modules. So it's great news that these universities are now backing the Certificate and enabling much greater choice for veterinary surgeons studying for the qualification."
Full details of the new modules are available on RCVSonline at www.rcvs.org.uk/modcerts
Kerrie was inspired in this by the results of her MBA dissertation, which looked at both enablers and barriers to leadership experienced by veterinary women and found that when it comes to partnership, women were much more likely to wait to be asked, rather than actively discussing the likelihood with the current practice partners.
Kerrie said: "The 29th of February was historically a time when it was acceptable for women to propose marriage. That's obviously a really outdated concept but we think it presents a great opportunity to encourage women in the profession to change their mindset and actively ask their boss if a partnership is a possibility either now or in the near future.
"It's the sort of proposal that will have a big impact on their future and we'd love to see more women take the driving seat and steer their own destiny. The message is: you don't have to wait to be asked - use the 29th as your excuse to pop the question!"
Kerrie's research also identified that enablers for female practice ownership included identifying as a leader at an early stage in a veterinary career, having parents who were business owners and being perceived to have more assertive or dominant personality traits.
However, Kerrie said: "While those are the factors that have helped women become leaders in the past, it doesn't mean our leaders of tomorrow have to meet those criteria and during my focus groups I found many women in the profession had a tremendous desire to lead, grow and inspire. We're looking within XLVets at ways we can remove barriers for women and increase access to leadership at every level, including supporting new start-up practices.
"We hope on the 29th February there will also be practice partners out there who might wonder why ‘she's never asked' and use this as an opportunity to talk about forming a lasting partnership. It's 2020 and there's no need for anyone to be shy about starting this important conversation."
Under the direction of Hilary Jackson and Rosanna Marsella, the manual has been revised and updated to provide a resource focused on the clinically relevant aspects of dermatological diseases. It also includes several new chapters and various sections have been expanded.
This new edition keeps the same format as the third edition. The initial chapters review the basic structure and function of the skin, discuss a logical approach to history-taking and outline the core investigative tests that can be performed. A separate chapter on skin cytology has been added to this edition, providing information on common skin diseases which the association says should be useful to all practitioners.
The introductory section is followed by chapters taking a problem-oriented approach to common dermatological conditions, including papules and pustules, scaling, and erosions and ulcerations. The chapters on pyoderma, ear disease and atopic dermatitis have been expanded and there are two new chapters dedicated to feline dermatological conditions.
A chapter covering the indications for allergy testing and the use of allergen-specific immunotherapy is also new to this edition. The main purpose of an allergy test is to confirm the clinical diagnosis of atopic disease and to identify the relevant allergens, which can then be selected for allergen-specific immunotherapy.
The final section of the manual focuses on the major skin diseases encountered in dogs and cats, and includes a chapter on topical treatments, which have an increasingly important role in the management of small animal dermatology patients, either as a sole therapy or as part of a multimodal treatment regime.
The BSAVA Manual of Canine and Feline Dermatology is available as a print edition (£90; £60 to BSAVA members), which can be bought at the BSAVA online shop, and a digital edition (£90; £60 to BSAVA members), accessible via the BSAVA Library.
For every 'Proud to support Dogs for Good' profile picture changed and tagged with @PetMagicMoments and #dogsaregood, Elanco will donate £1 to the charity that trains dogs to give life-changing assistance to people with disabilities.
The company is hoping to raise up to £5,000 for its long-term charity partner through the Pet Magic Moments - https://www.facebook.com/PetMagicMoments/ - Facebook picture initiative, with an overall aim of raising in excess of £15,000 in total for Dogs for Good to support the training of three assistance dogs.
Elanco says it will raise additional money through fundraising activities and employees will also be encouraged to carry out voluntary work to support Dogs for Good in the three days a year they are given to volunteer for worthwhile charities.
Matthew Rowe, marketing manager at Elanco Animal Health, said: "Our Dogs for Good Facebook picture initiative will help highlight the profile of this wonderful and inspiring charity, while raising funds to support the training of an assistance dog."
Dogs for Good (the new name for Dogs for the Disabled) is an innovative charity, exploring ways dogs can help people overcome specific challenges and enrich and improve lives and communities.
Its assistance dogs support adults and children with a range of disabilities and also children with autism. It trains activity and therapy dogs to work with specialist handlers in communities and schools and its Family Dog team also gives specialist advice and support to help people get the most out of their relationship with their pet dog.
For further information about the charity, visit www.dogsforgood.org or call on 01295 252600.
Vet History is part of a five year project to improve access to and awareness of the wealth of material held by the College, which began with the appointment of a qualified archivist in October 2015 and the creation of the online database which includes descriptions of material catalogued to international archive standards. The catalogue will be fully searchable with biographical profiles for major persons featured in the collections.
The papers of the prolific veterinary author and army veterinarian Major General Sir Frederick Smith (1857-1929) are amongst the first collections to be fully catalogued and described online. The material covers the length of Smith’s career from case notes recording treatment of army horses in India in the 1880s to correspondence from the last 20 years of his life, in which he wrote a four volume history of veterinary literature. Smith was involved in the Army Veterinary Service during the Second Anglo-Boer War and the First World War, and his honest and candid accounts of the loss of horses by the Army illustrate fascinating aspects of veterinary, social and military history.
Chris Gush, Executive Director, RCVS Knowledge said: "The launch of the Archives catalogue covers a critical and fascinating time in the nation’s history, both for the advances in veterinary science and its role in marinating a functioning British military presence in the 19th century. Through this unparalleled collection, RCVS Knowledge can be an invaluable source of information for academic research and the general public."
The RCVS Vet History project is ongoing, and further collections will be catalogued periodically over the next four years. Visitors are encouraged to check the catalogue regularly, and follow RCVS Knowledge’s Twitter feed for news and updates.
To see behind the scenes of the Project, and find out more about highlighted items, follow the Historical Collections blog here.
The RCVS Vet History Project is supported by The ALBORADA Trust.
The lecture, which will take place at 4:30pm on Friday 6th April in the Premier Lounge, Arena Birmingham, is presented by Dr Ivan Crotaz BVetMed MRCVS and human anaesthesiologist Dr Muhammed Nasir MBBS BSc FFARCSI MRCA (pictured right).
Chris Geddes MRCVS, Marketing Manager for Docsinnovent, says the lecture is not to be missed for two reasons: "Firstly, the topic is very current – a lot of new information is emerging about regurgitation and reflux in our veterinary patients. We are learning that the starving times we have all been recommending for years may not be ideal after all.
"Secondly, the lecture will be presented by both a vet with an interest in airway management (Dr Crotaz) and a renowned human anaesthesiologist (Dr Nasir) – so we as a profession can learn from what is happening in the field of human medicine."
The session will include a review of the situation in human anaesthesia. The anatomy of the upper airway and oesophagus of the major small animal veterinary species will be examined as well as the pathogenesis, occurrence and disease associated with reflux.
Pre-, intra- and post-operative management will be discussed, as well as current recommendations for starving veterinary patients.
The lecture is free for BSAVA attendees to attend and will be followed by drinks and nibbles supplied by Docsinnovent, who are also exhibiting at BSAVA congress on stand 1006.
The Royal Veterinary College has announced the appointment of Professor Stuart Reid as its new Principal and the successor to Professor Quintin McKellar.
Professor Reid BVMS, PhD, DVM, DipECVPH, FRSE, MRCVS, joins the RVC from the University of Glasgow, where he was Professor of Veterinary Informatics and Epidemiology and Head of the School of Veterinary Medicine. He will take up his new role on 1st January 2011.
Professor Reid began his career in 1987 as an Assistant Veterinary Surgeon before joining the University of Glasgow as a Clinical Research Scholar in 1988. In 1992 he assumed the role of Post Doctoral Research Fellow at the University and was promoted to Senior Post-Doctoral Research Fellow in 1994. He was appointed to the first joint Chair between the Universities of Strathclyde and Glasgow in 1997, as Professor of Veterinary Informatics and Epidemiology. In 2004 he became Associate Dean of Research and, in 2005, he became Dean of the Faculty of Veterinary Medicine at the University of Glasgow.
"I am delighted and honoured to be joining the Royal Veterinary College at this important time." said Professor Reid. "The RVC has an enviable heritage and is a world leader in terms of its innovation and leadership in veterinary education, research and clinical service. I recognise that I am enormously privileged to be moving from a great School to a great College and I look forward to building on the successes achieved by RVC under Principal McKellar at the same time as rising to the challenges of a new funding environment."
Professor Quintin McKellar was appointed Principal in August 2004. He leaves the RVC to take the post of Vice-Chancellor of the University of Hertfordshire.
Chairman of the RVC Council, The Right Hon the Baroness Shephard of Northwold, said: "Great strides have been made under Professor McKellar's dynamic leadership, and I am sure I speak for all at the College when I say we will be sad to see him go. We look forward to welcoming Professor Stuart Reid, and firmly believe that his experience and distinguished academic record will assist the Royal Veterinary College in strengthening its position over the coming years."
The BVA has paid tribute to Lord Ballyedmond, founder of the veterinary pharmaceutical company Norbrook Laboratories, after he was killed in a helicopter crash in Norfolk last Thursday.
The life peer (pictured second from left collecting a business award in 2011) founded Norbrook over 40 years ago. It became one of the biggest manufacturers of animal health products globally, and now employs more than 1000 people. Dr. Edward Haughey, as he was previously known, was ennobled in 2004.
Following his death, Norbrook issued the following statement:
"It is with sincere sadness and deep regret that the Company confirms our founding Chairman and CEO, Lord Ballyedmond, was one of four people who tragically lost their lives in an aviation accident at Gillingham, Norfolk at approximately 7.30pm on Thursday 13 March 2014.
Norbrook management and staff also mourn the loss of their friends and colleagues Declan Small (Site Foreman), Captain Carl Dickerson (Pilot) and Captain Lee Hoyle (Pilot).
Our thoughts are with the immediate families and friends of the deceased who have requested privacy at this difficult time.
We take enormous pride in our Chairman's extraordinary legacy in establishing Norbrook as a global veterinary and pharmaceutical industry leader. Management will continue to advance his pioneering vision with a renewed vigor and determination befitting his memory."
BVA President Robin Hargreaves said: "We are deeply saddened to hear of the tragic passing of Lord Ballyedmond. He has been a great supporter of the veterinary profession and of BVA, and made an enormous contribution to veterinary medicine. He built opportunity for thousands of people in Northern Ireland and around the world and had a huge commercial and industrial presence throughout my whole career. Above all Lord Ballyedmond was a family man and all our thoughts are with his wife and children at this time."
The voluntary scheme, which has been welcomed by Farming Minister George Eustice and Welsh Government Cabinet Secretary for Environment and Rural Affairs Lesley Griffiths, improves a herd’s ‘score’ every year it is free from a bTB breakdown, awarding a status of 0-10.
This new bTB scheme will require the herd vet and cattle owner to work together on following a number of biosecurity measures already successfully implemented in five other cattle disease control programmes.
As well as reducing risk of infection, the country-wide programme could present informed purchasing opportunities. In particular, it could benefit farmers selling cattle from regions with a high risk of the disease or who wish to minimise exposure from bought-in animals. It could also give recognition for a farmer’s efforts to complement Government and industry strategies to control infection.
Farming Minister George Eustice (pictured left above, with BCVA President Andrew Cobner) said: "Dealing with Bovine TB is costing us £100 million a year and causing devastation and distress for farmers and rural communities across the country. 33,000 cattle were slaughtered because of the disease last year alone and many farms are subject to movement restrictions which can affect their trade.
"But we know some 40% of herds in the high-risk area in England have never had a breakdown, and the CHeCS scheme will help them to communicate this so they can carry out risk-based trading to support their businesses.
"The scheme will also recognise those practicing good biosecurity, which is a core part of our long-term plan to tackle bovine TB."
The scheme complements the Government’s 25-year plan to eradicate Bovine TB in England, and will provide another tool for farmers who want to show they are following best practice. It follows the launch of the TB Hub (www.tbhub.co.uk), which offers practical advice and guidance as well as background into the disease.
The Cabinet Secretary, Mrs Griffiths, said: "The Welsh Government has been supportive of this initiative from the start. By focusing on individual herds, the scheme complements our proposed regional approach, for example those herds in the high TB areas which have not recently had TB will be able to demonstrate they are a lower risk.
"This industry-led initiative aimed at reducing TB is to be welcomed and fits in with our principles of working in partnership and promoting the benefits of disease prevention. I urge Welsh farmers to engage with the scheme and reduce the risk of disease being introduced into their herd."
Across Great Britain, CHeCS has over 14,000 member herds, representing around 14% of cattle holdings in some form of monitoring, control and eradication of disease.
Keith Cutler, CHeCS board member and partner in the Endell Veterinary Group, said: "CHeCS so far has focused on control of non-statutory diseases – Johne’s Disease, IBR, BVD, Leptospirosis and Neospora. Participating health schemes have been monitoring the health status of participating herds for some years.
"With this programme, we will be working with Government to receive official TB test data with the agreement of the farmer. It’s an exciting development for CHeCS, but there is a natural fit because of the expertise CHeCS-accredited health schemes already have with monitoring biosecurity measures on their members’ farms."
Andrew Cobner, president of the British Cattle Veterinary Association, who has been technical lead on the project since the start, said: "All too often we are confronted with the view that there is little or nothing that we can do to control TB. We wouldn’t accept this attitude with any other infectious disease so it’s time farmers and vets fought back. We have a government that is willing to embrace all of the measures necessary and we have a 25 year plan in place. Part of this will involve increasing biosecurity and risk-based trading, and CHeCS is leading the way."
The CHeCS bTb Herd Accreditation scores run from 0 (following all CHeCS measures but had a herd breakdown within the past 12 months), to 1 (following CHeCS measures and one year since the last herd breakdown) all the way though to 10 (following CHeCS measures and 10 years or more since the last herd breakdown).
Veterinary surgeons who think their clients might want to know more can point them in the direction of: www.checs.co.uk to read the technical standard, programme handbook and Q&A. If it sounds advantageous to their farm, they should discuss joining with you, then contact one of the participating CHeCS-accredited health schemes listed on the website. The application form includes a privacy agreement to allow the Animal and Plant Health Agency (APHA) to send test data automatically to the health scheme, and a declaration from the herd vet. After the form is sent back, a starting score will be awarded.
More information on bTB is also available at www.tbhub.co.uk.
A short survey, which has been emailed to BVA members this week, asks respondents to confirm which Official Controls Qualifications (OCQ(V)s) they currently hold or previously held.
They are also asked to give reasons if they have chosen to drop a particular qualification without revalidating it.
The BVA says members have raised concerns via Council about the OV training and revalidation process, citing time, cost, a lack of relevance and duplication of learning across different modules as reasons for choosing not to renew their qualifications.
The BVA plans to take the data and insights captured in the survey to the Animal and Plant Health Agency (APHA) and make recommendations for how the system can be made more user-friendly and fit for purpose.
John Fishwick, BVA President, said: "Official Veterinarians have a critical role to play in upholding high standards of health and welfare across the supply chain, certifying products for export and safeguarding against disease and food fraud. We are already aware that this area is facing significant challenges as Brexit is likely to drive up demand for product certification.
"It is particularly worrying to hear that members are finding the system both frustrating and resource-intensive. Losing skilled professionals now at a time when they are needed most would be a real waste of specialist knowledge and could leave gaps in the UK’s provision for responding to disease outbreaks and meeting export certification needs post-Brexit.
"We understand and support the need to keep veterinary skills up to date, but the process for demonstrating this must be straightforward and proportionate. BVA will ensure that all insights offered by respondents are raised with APHA with the aim of getting the system right for OVs working in the UK both now and in the future."
BVA members can access the survey at https://www.surveymonkey.co.uk/r/7Y2Y3RR. The deadline for responding is 29 June 2018.